Animal NDC 58198-0028-1 Cydectin

Moxidectin

Animal Product Information

Field Name Field Value
Animal NDC Code 58198-0028-1
Proprietary Name Cydectin What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
Non-Proprietary Name Moxidectin What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
Labeler Name Elanco Us Inc.
Product Type Otc Animal Drug
Usage Information
    CYDECTIN Injectable, when administered at the recommended dose level of 0.2 mg/2.2 lb (0.2 mg/kg) body weight, is effective in the treatment and control of the following internal and external parasites of cattle: Gastrointestinal RoundwormsLungwormsOstertagia ostertagi - Adults and L4(including inhibited Larvae)   Dictyocaulus viviparus - Adults and L4Haemonchus placei - Adults Cattle GrubsTrichostrongylus axei - Adults and L4  Hypoderma bovisTrichostrongylus colubriformis - Adults and L4  Hypoderma lineatumCooperia oncophora - Adults MitesCooperia pectinata - Adults   Psoroptes ovisCooperia punctata - Adults and L4  (Psoroptes communis var. bovis)Cooperia spatulata - Adults LiceCooperia surnabada - Adults and L4  Linognathus vituliNematodirus helvetianus - Adults   Solenopotes capillatusOesophagostomum radiatum - Adults and L4Trichuris spp. - Adults Persistent Activity: CYDECTIN Injectable has been proven to effectively protect cattle from reinfection with Dictyocaulus viviparus and Oesophagostomum radiatum for 42 days after treatment, Haemonchus placei for 35 days after treatment, and Ostertagia ostertagi and Trichostrongylus axei for 14 days after treatment. Management Considerations for External Parasites: For most effective external parasite control, CYDECTIN Injectable should be administered to all cattle in the herd. Cattle entering the herd following this administration should be treated prior to introduction. Consult your veterinarian or a livestock entomologist for the most appropriate time to administer CYDECTIN Injectable in your location to effectively control external parasites.
Active Ingredient(s)
  • Moxidectin
Marketing Category NADA - NEW ANIMAL DRUG APPLICATION What is the Marketing Category?
Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
FDA Application Number NADA141220 What is the FDA Application Number?
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.

Cydectin Animal Product Labeling Information

The product labeling information includes all published material associated to a drug. Product labeling documents include information like generic names, active ingredients, ingredient strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.

Table of Contents



Other



Approved by FDA under NADA # 141-220.

CYDECTINTM

moxidectin

Injectable Solution for Beef and Nonlactating Dairy Cattle

Antiparasitic

Contains 10 mg moxidectin/mL

Not for use in female dairy cattle 20 months of age or older (including dry dairy cows), veal calves, and calves less than 8 weeks of age.

For Treatment of Infections and Infestations Due to Internal and External Parasites of Cattle

Consult your veterinarian for assistance in the diagnosis, treatment and control of parasitism.

Not For Use in Humans. Keep this and all drugs out of the reach of children. For product questions, to report adverse reactions, or for a copy of the Safety Data Sheet (SDS), call Elanco Product & Veterinary Support at 1-800-428-4441.


Product Description



CYDECTIN Injectable Solution is a ready-to-use, sterile solution containing 1% moxidectin. Moxidectin is an endectocide in the milbemycin chemical class which shares the distinctive mode of action characteristic of macrocyclic lactones. CYDECTIN Injectable is specially formulated to allow moxidectin to be absorbed from the site of injection and distributed internally to the areas of the body affected by endo- and/or ectoparasitism. Moxidectin binds selectively and with high affinity to glutamate-gated chloride ion channels which are critical to the function of invertebrate nerve and muscle cells. This interferes with neurotransmission resulting in paralysis and elimination of the parasite.


Indications



CYDECTIN Injectable, when administered at the recommended dose level of 0.2 mg/2.2 lb (0.2 mg/kg) body weight, is effective in the treatment and control of the following internal and external parasites of cattle:

Gastrointestinal Roundworms

Lungworms

Ostertagia ostertagi - Adults and L4(including inhibited Larvae)

  Dictyocaulus viviparus - Adults and L4

Haemonchus placei - Adults

Cattle Grubs

Trichostrongylus axei - Adults and L4

  Hypoderma bovis

Trichostrongylus colubriformis - Adults and L4

  Hypoderma lineatum

Cooperia oncophora - Adults

Mites

Cooperia pectinata - Adults

  Psoroptes ovis

Cooperia punctata - Adults and L4

  (Psoroptes communis var. bovis)

Cooperia spatulata - Adults

Lice

Cooperia surnabada - Adults and L4

  Linognathus vituli

Nematodirus helvetianus - Adults

  Solenopotes capillatus

Oesophagostomum radiatum -

Adults and L4

Trichuris spp. - Adults

Persistent Activity: CYDECTIN Injectable has been proven to effectively protect cattle from reinfection with Dictyocaulus viviparus and Oesophagostomum radiatum for 42 days after treatment, Haemonchus placei for 35 days after treatment, and Ostertagia ostertagi and Trichostrongylus axei for 14 days after treatment.

Management Considerations for External Parasites: For most effective external parasite control, CYDECTIN Injectable should be administered to all cattle in the herd. Cattle entering the herd following this administration should be treated prior to introduction. Consult your veterinarian or a livestock entomologist for the most appropriate time to administer CYDECTIN Injectable in your location to effectively control external parasites.


Dosage



The recommended rate of administration for CYDECTIN Injectable is 1 mL for each 110 lb (50 kg) body weight to provide 0.2 mg moxidectin/2.2 lb (0.2 mg/kg) body weight. The table below will assist in the calculation of the appropriate volume of injectable which must be administered based on the weight of animal being treated. Be careful not to overdose animals; estimate animal’s body weight as closely as possible or weigh animals individually.

Weight (lb)

165

220

330

440

550

660

770

880

990

1100

Weight (kg)

75

100

150

200

250

300

350

400

450

500

Dose (mL)

1.5

2.0

3.0

4.0

5.0

6.0

7.0

8.0

9.0

10.0

  • •Do not underdose. Ensure each animal receives a complete dose based on a current body weight. Underdosing may result in ineffective treatment, and encourage the development of parasite resistance.

Administration



CYDECTIN Injectable should be administered by subcutaneous injection under the loose skin in front of or behind the shoulder (Figure 1). Needles 1/2 to 3/4 inch in length and 16 to 18 gauge are recommended for subcutaneous injections. Use sterile, dry equipment and aseptic procedures when withdrawing and administering CYDECTIN.

Figure 1. Sites for administration of CYDECTIN Injectable


Residue Warnings



Cattle must not be slaughtered for human consumption within 21 days of treatment. This drug product is not approved for use in female dairy cattle 20 months of age or older, including dry dairy cows. Use in these cattle may cause drug residues in milk and/or in calves born to these cows. A withdrawal period has not been established for preruminating calves. Do not use in calves to be processed for veal.


Animal Safety Warnings



Do not use in sick, debilitated, or underweight animals. In foreign countries there have been reports of adverse effects, including death. This product should not be used in calves less than 8 weeks of age because safety testing has not been done in the U.S. in calves less than 8 weeks of age.


Environmental Warnings



Studies indicate that when moxidectin comes in contact with the soil, it readily and tightly binds to the soil and becomes inactive. Free moxidectin may adversely affect fish and certain aquatic organisms. Do not contaminate water by direct application or by improper disposal of drug containers.


Other Warnings



  • •Parasite resistance may develop to any dewormer, and has been reported for most classes of dewormers.
  • •Treatment with a dewormer used in conjunction with parasite management practices appropriate to the geographic area and the animal(s) to be treated may slow the development of parasite resistance.
  • •Fecal examinations or other diagnostic tests and parasite management history should be used to determine if the product is appropriate for the herd/flock, prior to the use of any dewormer. Following the use of any dewormer, effectiveness of treatment should be monitored (for example, with the use of a fecal egg count reduction test or another appropriate method).
  • •A decrease in a drug’s effectiveness over time as calculated by fecal egg count reduction tests may indicate the development of resistance to the dewormer administered. Your parasite management plan should be adjusted accordingly based on regular monitoring.

Precautions



CYDECTIN Injectable has been formulated specifically for subcutaneous injection in cattle and should not be given by other routes of administration. Subcutaneous injection can cause transient local tissue reaction that may result in trim loss of edible tissue at slaughter if animals are slaughtered within 35 days after treatment. This product should not be used in other animal species as severe adverse reactions, including fatalities in dogs, may result.

CYDECTIN Injectable is effective against the migrating stage of cattle grubs (Hypoderma larvae). Treatment with CYDECTIN Injectable during the period when grubs are migrating through vital areas may cause undesirable host-parasite reactions. Killing H. lineatum when they are located in peri-esophageal tissues may cause bloat. Killing H. bovis when they are in the vertebral canal may cause staggering or hindlimb paralysis. Cattle should be treated as soon as possible after heel fly (warble fly) season to avoid this potential problem. Cattle treated with CYDECTIN Injectable at the end of fly season can be retreated during the winter without danger of grub-related reactions. Consult your veterinarian for more information regarding these secondary grub reactions and the correct time to treat with CYDECTIN Injectable.


Animal Safety



U.S. tolerance and toxicity studies have demonstrated that CYDECTIN Injectable has an adequate margin of safety for use in cattle 8 weeks of age and older. No toxic signs were seen in growing cattle given up to 5 times the recommended dose. Calves as young as 8 weeks of age showed no toxic signs when treated with up to 3 times the recommended dose while nursing from cows concurrently treated with the recommended dose level of CYDECTIN Injectable. Mild, transient ataxia was noted in growing cattle receiving 10 times the recommended dose and in bulls treated at 4.5 times the recommended dose. In breeding animals (bulls and cows in estrous and during early, mid and late pregnancy), treatment with at least 3 times the recommended dose had no effect on breeding performance.

Signs of toxicity include ataxia, excessive salivation, depression, and mydriasis. These signs usually occur within 12 to 48 hours post-treatment.


Storage



Store product at or below 77°F (25°C). Protect from light. Use contents within 12 months of first puncture.


Disposal



Do not contaminate water by direct application or by improper disposal of drug containers. Dispose of containers in an approved landfill or by incineration.


Package Information



CYDECTIN Injectable is available in 500 mL amber glass bottles.

Restricted Drug (CA) - Use Only As Directed.

Patent information at http://www.elancopatents.com

Manufactured for:
Elanco US Inc.
Greenfield, IN  46140   U.S.A

Made in China
Made in Italy

Cydectin, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.
© 2023 Elanco or its affiliates.

Revised: September 2023

YL600406A
YL600406B

Elanco


Principal Display Panel - 500 Ml Bottle Label



Elanco

CYDECTINTM

moxidectin

Injectable Solution for Beef
and Nonlactating Dairy Cattle

Antiparasitic

Sterile

Contains 10 mg moxidectin/mL (5,000 mg/500 mL)

Not for use in female dairy cattle 20 months of age
or older (including dry dairy cows), veal calves,
and calves less than 8 weeks of age.

For Treatment of Infections and
Infestations Due to Internal
and External Parasites
of Cattle.

Contents 500 mL
             (16.91 oz)

Approved by FDA under NADA# 141-220.


* The information on this page is for an ANIMAL PRODUCT, please review the complete disclaimer below.